| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 45.171 | 176.345 | 395.273 | 1.153.731 | 868.272 | 990.294 |
| Total Income - EUR | - | - | - | - | 45.361 | 176.917 | 396.865 | 1.161.123 | 873.439 | 992.131 |
| Total Expenses - EUR | - | - | - | - | 50.669 | 167.738 | 342.855 | 977.920 | 821.257 | 997.722 |
| Gross Profit/Loss - EUR | - | - | - | - | -5.308 | 9.179 | 54.011 | 183.203 | 52.182 | -5.591 |
| Net Profit/Loss - EUR | - | - | - | - | -5.978 | 7.505 | 50.527 | 170.077 | 44.920 | -5.591 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 3 |
Check the financial reports for the company - Nidev Bio Group S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 1.148 | 936 | 2.938 | 4.845 | 9.100 | 21.781 |
| Current Assets | - | - | - | - | 59.624 | 123.911 | 169.761 | 320.873 | 434.481 | 372.345 |
| Inventories | - | - | - | - | 57.127 | 107.136 | 116.968 | 139.400 | 247.876 | 190.864 |
| Receivables | - | - | - | - | 1.132 | 7.361 | 46.490 | 134.155 | 139.888 | 124.856 |
| Cash | - | - | - | - | 1.365 | 9.414 | 6.302 | 47.318 | 46.717 | 56.625 |
| Shareholders Funds | - | - | - | - | -5.914 | 1.703 | 52.192 | 195.537 | 205.913 | 38.067 |
| Social Capital | - | - | - | - | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | - | - | - | 66.686 | 123.212 | 120.612 | 130.260 | 237.747 | 356.109 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Nidev Bio Group S.r.l.